PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

IV Iron Cuts Transfusion Risk in Anemic Pregnancy

intravenous ironoral ironiron sucroseferric carboxymaltoseiron deficiency anemiapregnancyblood transfusionmeta-analysiswomen's healthmaternal-fetal medicine Women's Health / Reproductive

Background Information

IV iron outperforms oral iron for treating anemia in pregnancy.

Iron deficiency anemia (IDA) during pregnancy can adversely affect maternal and neonatal outcomes. Determining the optimal route of iron therapy is crucial for effective management. Intravenous (IV) iron was shown to significantly improve maternal hemoglobin and ferritin levels, increase neonatal iron stores, and reduce blood transfusion rates compared to oral iron, particularly in women with lower pretreatment hemoglobin levels. This study supports IV iron as a more effective treatment than oral iron for pregnant women with IDA, with fewer adverse effects, which could influence treatment protocols. IV iron improves maternal and neonatal outcomes in pregnancy-related IDA more effectively than oral iron.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Sales SK, Rajprohat S, Simon L, Hardi A, Stoll C, Benson AE, Shatzel JJ, Lo JO, Tuuli MG, Lewkowitz AK

Citation: Sales SK, Rajprohat S, Simon L, et al. Intravenous vs Oral Iron for Treating Iron Deficiency Anemia in Pregnancy: A Systematic Review and Meta-Analysis. JAMA network open. 2026;9(9):e2630657. doi:10.1001/jamanetworkopen.2026.30657

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.